<p>Oaktree Acquisition Corp. III Life Sciences（纳斯达克代码：OACC - 获取免费报告）的股价在周三上涨了 0.3%。该股交易最高达到 10.60 美元，最后交易价为 10.60 美元。在午盘交易中，共成交 1,053 股，较平均交易量 58,164 股下降了 98%。该股此前收盘价为 10.57 美元。</p>
<h2>分析师评级变动</h2>
<p>另外，Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Oaktree Acquisition Corp. III Life Sciences 的 “卖出（d-）” 评级。一位研究分析师对该股给予了卖出评级，根据 MarketBeat 的数据，该股目前的平均评级为 “卖出”。</p>
<p><strong>查看我们对 OACC 的最新分析</strong></p>
<h2>Oaktree Acquisition Corp. III Life Sciences 股票表现</h2>
<p>该公司的 50 日移动平均价格为 10.58 美元，200 日移动平均价格为 10.51 美元。</p>
<h2>机构资金流入和流出</h2>
<p>一些机构投资者最近对该公司的持仓进行了调整。Driehaus Capital Management LLC 在第一季度购买了 Oaktree Acquisition Corp. III Life Sciences 的新股份，价值 918 万美元。Lighthouse Investment Partners LLC 在第二季度将其在 Oaktree Acquisition Corp. III Life Sciences 的持股增加了 88.9%。Lighthouse Investment Partners LLC 目前拥有该公司 850,000 股股票，价值 8,882,000 美元，此前在上一季度又购买了 400,000 股。Linden Advisors LP 在第一季度购买了 Oaktree Acquisition Corp. III Life Sciences 的新股份，价值约 612 万美元。高盛集团在第一季度购买了 Oaktree Acquisition Corp. III Life Sciences 的新股份，价值约 541.7 万美元。最后，Moore Capital Management LP 在第二季度购买了 Oaktree Acquisition Corp. III Life Sciences 的新股份，价值约 550.2 万美元。</p>
<h2>关于 Oaktree Acquisition Corp. III Life Sciences</h2>
<p>（获取免费报告）</p>
<p>Oaktree Acquisition Corp. III Life Sciences 是一家空白支票公司，成立的目的是进行合并、资本股票交换、资产收购、股票购买、重组或与一家或多家企业进行类似的商业组合。该公司成立于 1995 年，总部位于加利福尼亚州洛杉矶。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票超过 Oaktree Acquisition Corp. III Life Sciences</li>
<li>5 个适合股息增长投资者的折扣机会</li>
<li>市场动量：3 只有望大幅突破的股票</li>
<li>什么是股息挑战者？</li>
<li>3 个理由说明 Casey’s General Stores 将继续上涨</li>
<li>交易暂停解释</li>
<li>黄金交叉警报：3 只具有重大上涨潜力的股票</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Oaktree Acquisition Corp. III Life Sciences 吗？</h2>
<p>在考虑 Oaktree Acquisition Corp. III Life Sciences 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在就买入，以便在更广泛的市场注意到之前……而 Oaktree Acquisition Corp. III Life Sciences 并不在名单上。</p>
<p>虽然 Oaktree Acquisition Corp. III Life Sciences 目前在分析师中被评为卖出，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OACC

<p>Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) 的股价上涨了 0.3%，达到 10.60 美元，尽管 Weiss Ratings 给予了 “卖出” 评级。交易量明显低于平均水平。机构投资者已调整其持仓，Driehaus Capital Management 和 Lighthouse Investment Partners 进行了显著的购买。分析师建议其他股票可能是更好的投资选择</p>

<p>Shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Get Free Report) shot up 0.3% on Wednesday . The stock traded as high as $10.60 and last traded at $10.60. 1,053 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 58,164 shares. The stock had previously closed at $10.57.</p>
<div class="lb-trans"><p>Oaktree Acquisition Corp. III Life Sciences（纳斯达克代码：OACC - 获取免费报告）的股价在周三上涨了 0.3%。该股交易最高达到 10.60 美元，最后交易价为 10.60 美元。在午盘交易中，共成交 1,053 股，较平均交易量 58,164 股下降了 98%。该股此前收盘价为 10.57 美元。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Separately, Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of Oaktree Acquisition Corp. III Life Sciences in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of &#34;Sell&#34;.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Oaktree Acquisition Corp. III Life Sciences 的 “卖出（d-）” 评级。一位研究分析师对该股给予了卖出评级，根据 MarketBeat 的数据，该股目前的平均评级为 “卖出”。</p>
</div><p><strong>View Our Latest Analysis on OACC</strong></p>
<div class="lb-trans"><p><strong>查看我们对 OACC 的最新分析</strong></p>
</div><h2>Oaktree Acquisition Corp. III Life Sciences Stock Performance</h2>
<div class="lb-trans"><h2>Oaktree Acquisition Corp. III Life Sciences 股票表现</h2>
</div><p>The company's 50 day moving average price is $10.58 and its 200-day moving average price is $10.51.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均价格为 10.58 美元，200 日移动平均价格为 10.51 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors have recently made changes to their positions in the company. Driehaus Capital Management LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth $9,180,000. Lighthouse Investment Partners LLC lifted its holdings in Oaktree Acquisition Corp. III Life Sciences by 88.9% during the second quarter. Lighthouse Investment Partners LLC now owns 850,000 shares of the company's stock valued at $8,882,000 after purchasing an additional 400,000 shares during the last quarter. Linden Advisors LP bought a new position in Oaktree Acquisition Corp. III Life Sciences during the first quarter worth about $6,120,000. Goldman Sachs Group Inc. purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the first quarter worth about $5,417,000. Finally, Moore Capital Management LP bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the second quarter valued at approximately $5,502,000.</p>
<div class="lb-trans"><p>一些机构投资者最近对该公司的持仓进行了调整。Driehaus Capital Management LLC 在第一季度购买了 Oaktree Acquisition Corp. III Life Sciences 的新股份，价值 918 万美元。Lighthouse Investment Partners LLC 在第二季度将其在 Oaktree Acquisition Corp. III Life Sciences 的持股增加了 88.9%。Lighthouse Investment Partners LLC 目前拥有该公司 850,000 股股票，价值 8,882,000 美元，此前在上一季度又购买了 400,000 股。Linden Advisors LP 在第一季度购买了 Oaktree Acquisition Corp. III Life Sciences 的新股份，价值约 612 万美元。高盛集团在第一季度购买了 Oaktree Acquisition Corp. III Life Sciences 的新股份，价值约 541.7 万美元。最后，Moore Capital Management LP 在第二季度购买了 Oaktree Acquisition Corp. III Life Sciences 的新股份，价值约 550.2 万美元。</p>
</div><h2>About Oaktree Acquisition Corp. III Life Sciences</h2>
<div class="lb-trans"><h2>关于 Oaktree Acquisition Corp. III Life Sciences</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.</p>
<div class="lb-trans"><p>Oaktree Acquisition Corp. III Life Sciences 是一家空白支票公司，成立的目的是进行合并、资本股票交换、资产收购、股票购买、重组或与一家或多家企业进行类似的商业组合。该公司成立于 1995 年，总部位于加利福尼亚州洛杉矶。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Oaktree Acquisition Corp. III Life Sciences</li>
<li>5 discounted opportunities for dividend growth investors</li>
<li>Market Momentum: 3 Stocks Poised for Major Breakouts</li>
<li>What Are Dividend Challengers?</li>
<li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li>
<li>Trading Halts Explained</li>
<li>Golden Cross Alert: 3 Stocks With Major Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Oaktree Acquisition Corp. III Life Sciences</li>
<li>5 个适合股息增长投资者的折扣机会</li>
<li>市场动量：3 只有望大幅突破的股票</li>
<li>什么是股息挑战者？</li>
<li>3 个理由说明 Casey’s General Stores 将继续上涨</li>
<li>交易暂停解释</li>
<li>黄金交叉警报：3 只具有重大上涨潜力的股票</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oaktree Acquisition Corp. III Life Sciences Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Oaktree Acquisition Corp. III Life Sciences 吗？</h2>
</div><p>Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Oaktree Acquisition Corp. III Life Sciences 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在就买入，以便在更广泛的市场注意到之前……而 Oaktree Acquisition Corp. III Life Sciences 并不在名单上。</p>
</div><p>While Oaktree Acquisition Corp. III Life Sciences currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Oaktree Acquisition Corp. III Life Sciences 目前在分析师中被评为卖出，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Oaktree Acquisition Corp III Life Sciences (NASDAQ:OACC) 股价上涨 0.3% - 仍然是买入的好时机吗？